| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
41,099 |
31,960 |
$2.35M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,539 |
2,182 |
$191K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,416 |
1,353 |
$109K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,886 |
4,123 |
$100K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,400 |
1,310 |
$57K |
| 36415 |
Collection of venous blood by venipuncture |
4,001 |
3,608 |
$47K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,880 |
1,540 |
$20K |
| 71046 |
Radiologic examination, chest; 2 views |
530 |
467 |
$19K |
| 81000 |
|
635 |
546 |
$12K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,055 |
1,617 |
$11K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
256 |
245 |
$9K |
| 81025 |
|
632 |
598 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
368 |
349 |
$6K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
144 |
138 |
$5K |
| 3008F |
|
356 |
300 |
$5K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
100 |
91 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
121 |
117 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
133 |
121 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
215 |
151 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
80 |
74 |
$2K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
108 |
106 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
26 |
26 |
$2K |
| 99441 |
|
128 |
104 |
$2K |
| 81002 |
|
656 |
601 |
$2K |
| 90688 |
|
46 |
43 |
$2K |
| 20610 |
|
30 |
27 |
$1K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
12 |
12 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
28 |
26 |
$981.13 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13 |
13 |
$923.78 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
234 |
157 |
$597.79 |
| Q3014 |
Telehealth originating site facility fee |
22 |
20 |
$514.85 |
| 90733 |
|
79 |
79 |
$295.40 |
| 74018 |
|
18 |
14 |
$262.58 |
| 90686 |
|
48 |
45 |
$137.06 |
| 81003 |
|
51 |
47 |
$52.25 |
| 99072 |
|
76 |
67 |
$20.00 |
| 96156 |
|
17 |
16 |
$0.00 |
| 90715 |
|
13 |
13 |
$0.00 |